340 related articles for article (PubMed ID: 23736028)
1. Functional and cancer genomics of ASXL family members.
Katoh M
Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
[TBL] [Abstract][Full Text] [Related]
2. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
Katoh M
Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of ASXL3 gene in silico.
Katoh M; Katoh M
Int J Oncol; 2004 Jun; 24(6):1617-22. PubMed ID: 15138607
[TBL] [Abstract][Full Text] [Related]
4. The Role of Additional Sex Combs-Like Proteins in Cancer.
Micol JB; Abdel-Wahab O
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27527698
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.
Awamleh Z; Chater-Diehl E; Choufani S; Wei E; Kianmahd RR; Yu A; Chad L; Costain G; Tan WH; Scherer SW; Arboleda VA; Russell BE; Weksberg R
Eur J Hum Genet; 2022 Jun; 30(6):695-702. PubMed ID: 35361921
[TBL] [Abstract][Full Text] [Related]
6. ASXL gain-of-function truncation mutants: defective and dysregulated forms of a natural ribosomal frameshifting product?
Dinan AM; Atkins JF; Firth AE
Biol Direct; 2017 Oct; 12(1):24. PubMed ID: 29037253
[TBL] [Abstract][Full Text] [Related]
7. Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx.
Baskind HA; Na L; Ma Q; Patel MP; Geenen DL; Wang QT
PLoS One; 2009; 4(3):e4750. PubMed ID: 19270745
[TBL] [Abstract][Full Text] [Related]
8. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.
Abdel-Wahab O; Dey A
Leukemia; 2013 Jan; 27(1):10-5. PubMed ID: 23147254
[TBL] [Abstract][Full Text] [Related]
9. The HARE-HTH and associated domains: novel modules in the coordination of epigenetic DNA and protein modifications.
Aravind L; Iyer LM
Cell Cycle; 2012 Jan; 11(1):119-31. PubMed ID: 22186017
[TBL] [Abstract][Full Text] [Related]
10. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of ASXL2 gene in silico.
Katoh M; Katoh M
Int J Oncol; 2003 Sep; 23(3):845-50. PubMed ID: 12888926
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family.
Fisher CL; Randazzo F; Humphries RK; Brock HW
Gene; 2006 Mar; 369():109-18. PubMed ID: 16412590
[TBL] [Abstract][Full Text] [Related]
13. ASXL1/2 mutations and myeloid malignancies.
Medina EA; Delma CR; Yang FC
J Hematol Oncol; 2022 Sep; 15(1):127. PubMed ID: 36068610
[TBL] [Abstract][Full Text] [Related]
14. Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma}.
Park UH; Yoon SK; Park T; Kim EJ; Um SJ
J Biol Chem; 2011 Jan; 286(2):1354-63. PubMed ID: 21047783
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia.
Fisher CL; Pineault N; Brookes C; Helgason CD; Ohta H; Bodner C; Hess JL; Humphries RK; Brock HW
Blood; 2010 Jan; 115(1):38-46. PubMed ID: 19861679
[TBL] [Abstract][Full Text] [Related]
16. Familial and Somatic
Peng H; Prokop J; Karar J; Park K; Cao L; Harbour JW; Bowcock AM; Malkowicz SB; Cheung M; Testa JR; Rauscher FJ
Cancer Res; 2018 Mar; 78(5):1200-1213. PubMed ID: 29284740
[TBL] [Abstract][Full Text] [Related]
17. Repression of LXRα by a novel member of additional sex comb-like family, ASXL3.
Shin N; Lee YK; Park UH; Jeong JC; Um SJ
Biochem Biophys Res Commun; 2014 Nov; 454(4):479-85. PubMed ID: 25450400
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding.
Burgess AE; Kleffmann T; Mace PD
J Mol Biol; 2021 Nov; 433(22):167242. PubMed ID: 34536441
[TBL] [Abstract][Full Text] [Related]
19. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
[TBL] [Abstract][Full Text] [Related]
20. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.
Cuddapah VA; Dubbs HA; Adang L; Kugler SL; McCormick EM; Zolkipli-Cunningham Z; Ortiz-González XR; McCormack S; Zackai E; Licht DJ; Falk MJ; Marsh ED
Am J Med Genet A; 2021 Jun; 185(6):1700-1711. PubMed ID: 33751773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
